Shanghai Zhanquan Medical Technology Co., Ltd. was established in 2019, headquartered in Pudong New Area, Shanghai. It is a core subsidiary of Merck Healthcare Group, specializing in high-end medical equipment and in vitro diagnostics (IVD).
Relying on the deep accumulation of the group in the medical and health industry, Zhanquan Medical adheres to the mission of "technological innovation and global market expansion", and is committed to providing intelligent and precise medical solutions for global medical institutions.
Accurate diagnosis solution, rapid detection of multiple diseases
Full chain supply of NMPA Class III medical devices
Constructing a tumor closed-loop system through "medical examination drug insurance"
AI+deep application of big data, empowering intelligent diagnosis
VISION
Future vision
Innovation driven, global leader
Zhanquan Medical will continue to deepen the core concept of "innovation driven health" and accelerate the iteration and global layout of IVD technology. By deeply integrating AI, 5G, and medical devices, we aim to create an internationally leading intelligent healthcare solution platform, providing more efficient and inclusive medical services to patients worldwide, and fulfilling our long-term mission of promoting human health.